Phase 3 Herniorrhaphy for Postoperative Pain

• Status: Recruiting
• Trial end date: 2023-11-30
• Target enrollment: 0
• Participant gender: All

Summary

Subjects receive either CPL-01, positive control, or negative control after herniorrhaphy and are then followed.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cali Pharmaceuticals LLC
• Treatments: Anesthetics; Anesthetics, Local

Criteria

Inclusion Criteria:

• Able to sign Informed Consent; Scheduled to have inguinal hernia repair; others

Exclusion Criteria:

• Opioid abuse; others